Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome
About
Immune-mediated, non-communicable diseases, such as autoimmune diseases, allergic diseases and asthma, are chronic disorders in which the immune system plays a pivotal role. The World Health Organisation (WHO) has highlighted the seriousness of autoimmunity and its association with exposure to the environment.
EXIMIOUS aims to deliver a new way of assessing the human exposome, i.e. the exposures to environmental factors that one experiences throughout life, and shed light on its association to immune-mediated diseases.
Network
EXIMIOUS is part of the European Human Exposome Network and brings together 15 partner organisations from 7 European countries.
FAQ
Don’t know what the exposome is?
Want to know more about exposure-related immune diseases?
Curious to know more about what to expect from this project?
Project facts
EXIMIOUS is a 5 year Research and Innovation Action funded by the European Union’s Horizon 2020 programme.
- Concept: introduce a new approach to mapping exposure-induced immune effects by combining exposomics and immunomics in a unique toolbox.
- Budget: 10.8 million Euro
- Duration: 01.01.2020 - 31.12.2024
Latest news
Partner in the spotlight: accelopment Schweiz AG
This month we’re pleased to introduce accelopment Schweiz AG, our EXIMIOUS partner in the lead for the project’s communication, dissemination and exploitation . Based in Zürich, Switzerland, accelopment has been a sparring partner in the acquisition, management and communication and dissemination support of EU funded projects for research and innovation since 2008.
Watch the EXIMIOUS-EPHOR Joint Symposium at IOHA 2021
Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome Watch the EXIMIOUS-EPHOR Joint Symposium at IOHA 2021 16 November 2021 You can now rewatch the symposium titled ‘Exposure assessment in the exposome context – need for precise – broad-scope – external exposure assessment’, which was held at the IOHA 2021 international conference (11-15 September
Latest Tweets
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874707.